Subscribe
News

Pfizer and BioNTech ask FDA to authorize omicron-specific COVID-19 booster

By Abigail Adcox
Published
Add Washington Examiner on Google
Pfizer and BioNTech ask FDA to authorize omicron-specific COVID-19 booster

Pfizer and BioNTech announced Monday that they have submitted a bivalent COVID-19 booster to the Food and Drug Administration for emergency use authorization for people ages 12 and older.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Biden Administration Department of Health and Human Services Doctors Health Insurance